Document is current
Any future updates will be listed below
-
Authors
Reimold, Philipp https://orcid.org/0000-0002-7745-5762
Aksoy, Cem
Beckmann, Jonas
Zacharis, Aristeidis
Groeben, Christer
Karschuck, Philipp
Eisenmenger, Nicole
Geks, Josef
Huber, Johannes
Flegar, Luka
- License Information
-
More Information
Article History
Received: 5 August 2023
Accepted: 8 November 2023
First Online: 1 February 2024
Declaration
:
: Mrs. Eisenmenger is founder and director of RI Innovation GmbH. J. Huber is Medical Board member of the “Urologische Stiftung Gesundheit gGmbH,” Chairman of the Working Group “Health Services Research, Quality and Economics” of the German Society of Urology e. V. and initiator of the “Entscheidungshilfe Prostatakrebs” (). The latter is supported by Takeda Pharma, Janssen Cilag GmbH and APOGEPHA. He further indicates support of scientific projects outside the submitted work by Intuitive Surgical and Coloplast. All the other authors have no conflicts of interest to declare.
